July 30 (Reuters) - Becton Dickinson and Co BDX.N:
BD RECEIVES FDA 510(K) CLEARANCE FOR RAPID POINT-OF-CARE COVID-19 TEST
BECTON DICKINSON AND CO - 510(K) CLEARANCE TO REPLACE EUA VERSION OF TEST IN FALL 2025
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.